期刊文献+

^(99m)Tc-MIBI脑显像诊断脑肿瘤的初步应用 被引量:7

The preliminary application of 99m Tc MIBI SPECT in the diagnosis of brain tumor
下载PDF
导出
摘要 目的探讨99mTc甲氧基异丁基异腈(MIBI)脑显像对脑肿瘤的诊断价值。方法对8例正常对照者和31例脑肿瘤患者分别行99mTcMIBI脑血流显像和断层显像。脑血流显像观察病变部位血液供应情况;断层显像分别于注射后15~30分钟(早期相)和2~3小时(延迟相)进行,观察病变部位摄取99mTcMIBI的情况,并在横断面或冠状面图像上,分别计算早期相和延迟相肿瘤部位(T)与对侧(C)和脉络丛(CP)单位象素的放射性计数比值(T/C和T/CP),进行半定量分析。结果血流显像脑肿瘤组12例异常。断层显像所有受检者早期相和晚期相均可见CP部位放射性浓集,正常对照组脑实质内无放射性浓集;脑肿瘤组20例显像阳性,肿瘤部位放射性异常浓集,T/C及T/CP较对照组高。99mTcMIBI检出脑肿瘤的灵敏度和特异性分别为645%和100%。 Purpose To evaluate the value of the brain 99m Tc MIBI SPECT for detecting brain tumor Methods 31 patients with brain tumor and 8 normal controls underwent both dynamic imaging and SPECT, followed by semiquantitative analysis SPECT included early and delay phases The early and delay SPECT were acquired 15~30min and 2~3hr after injection of 555~925MBq 99m Tc MIBI respectively SPECT semiquantitative assessment of tracer uptake were made using a ratio of radioactivity in tumor containing areas compared to contralateral areas (T/C) and to choroid plexus (T/CP) Results 12 out of 31 patients were abnormal in dynamic study It was observed that there was consistant and prominent uptake of 99m Tc MIBI in the normal choroid plexus The radioactivity was observed in 20 out of 31 brain tumors The sensitivity and specificity were 64 5% and 100% respectively Conclusions The brain 99m Tc MIBI SPECT has clinical significance in detecting brain tumor
出处 《中华核医学杂志》 CAS CSCD 北大核心 1998年第1期30-31,共2页 Chinese Journal of Nuclear Medicine
关键词 脑肿瘤 放射性核素显像 锝99M MIBI Brain neoplasms Radionuclide imaging Nitriles
  • 相关文献

同被引文献55

  • 1孙爱君,孙磊,王荣福,刘健,吕强.^(18)F-FDG PET鉴别脑肿瘤放射治疗后复发和坏死的价值[J].中国医学影像技术,2004,20(10):1484-1486. 被引量:3
  • 2赵晋华.显示脑肿瘤活力的四种SPECT显像剂[J].国外医学(放射医学核医学分册),1996,20(2):53-57. 被引量:5
  • 3张忠,江涛,王忠诚.功能区胶质瘤的手术治疗进展[J].中国微侵袭神经外科杂志,2006,11(2):88-90. 被引量:21
  • 4宋锦宁 张芬茹 王茂德 等.99mTc-MIBISPECT显像对脑肿瘤的诊断价值研究[J].中国医学影像技术,2001,17:5-6.
  • 5Lumachi F, Tregnaghi A, Zucchetta P, et al. 99Tcm sestamibi scintigraphy and helical CT together in patients with primary hyper- parathyroidism: a prospective clinical study. Br J Radiol, 2004, 77 : 100-103.
  • 6Papantoniou V, Tsiouris S, Mainta E, et al. Imaging in situ breast carcinoma (with or without an invasive component) with 99Tcm pentavalent dimercaptosuccinic acid and 99Tcm 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res, 2005, 7: 33- 45.
  • 7Liu ZJ, Zhang YX, Zhang P, et al. Clinical investigation of 99Tcm-MIBI imaging in head and neck tumors. Chinese-German J Clin Oncol, 2006, 5 : 13-17.
  • 8Sato T, Kawabata Y, Saigo Y, et al. Interpretation of scintigraphic findings of oral malignant tumors with a new scanning agent of 99Tcm- hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI). Dentomaxillo fac Radiol, 2006: 24-29.
  • 9Wong M, Evans S, Rivory LP, et al. Hepatic 99Tcm-labeled sesta- mibi elimination rate and ABCB1 ( MDR1 ) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clin Pharmacol Ther, 2005, 77: 33-42.
  • 10Hamilton R J, Blend M J, Pelizzari CA, et al. Using vascular structure for CT-SPECT registration in the pelvis. J Nucl Med, 1999, 40 : 347-351.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部